HbO2 Therapeutics
Mr. Zafirelis has more than 25 years of CEO experience in private and public companies, including start-up ventures and turnaround situations. He led the original team at Biopure that developed Oxyglobin®, the veterinary oxygen carrier, now approved by FDA and EMA. Previously he led two cardiac device (class 3) companies, Cardiac Assist (Tandemheart) and Medquest Products and has significant experience with regulatory agencies worldwide. Mr. Zafirelis has an MS in Chemistry and an MBA from the University of Southern California. He has also completed the Corporate Director Program at Harvard Business School.
This person is not in any offices
HbO2 Therapeutics
1 followers
Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics) is a leading developer and manufacturer of oxygen-carrying solutions, a class of drug products that when administered intravenously can increase the amount of oxygen transported throughout the body.